A physician–pharmacologist with over eight years of clinical experience in emergency medicine and general practice, I am currently pursuing an MD in Pharmacology with a strong focus on translational and clinical pharmacology. My professional journey reflects a deliberate transition from frontline patient care to systems-level evaluation of medicines, drug safety, and therapeutic decision-making. My core areas of interest include pharmacovigilance, experimental pharmacology, clinical research methodology, and regulatory science. I actively engage in academic research, scientific writing, and conference presentations, with experience in in-vitro and in-silico pharmacological models. With a unique blend of clinical insight and pharmacological expertise, I aspire to contribute to evidence-based innovation and strategic roles within the pharmaceutical industry.

Manori Jayasinghe is a lecturer in pharmacy at the Faculty of Allied Health Sciences, University of Ruhuna, Sri Lanka, and a PhD candidate at the University of Sydney, Australia. Her research focuses on pharmaceutical policy, governance, accountability, and medicine pricing, with an emphasis on affordability, access, and safe use of medicines in low- and middle-income health systems. Her work contributes to interdisciplinary research on health system strengthening and evidence-informed pharmacology and public health policy.

Francis is a Lecturer of pharmacology at Gulu University (Uganda) and currently a Postdoc at the Infectious Diseases Institute (Uganda). He holds a Bachelors of Science degree in Biochemistry and a Masters of Science degree in pharmacology, both from Makerere University, and a Doctoral degree in pharmacometrics from the Freie Universitaet Berlin (Germany). Francis’s research has applied pharmacometrics in different therapeutic areas, including paediatrics and adult oncology, and infectious diseases such as malaria and HIV, characterising the relationship between treatment and treatment outcome (safety and efficacy). His current research focuses on pharmacometrics-based optimisation of treatment in special populations including pregnant and breastfeeding mother-infant pairs. He is passionate about teaching and mentoring junior scientists into pharmacometrics and increasing the role of pharmacometrics in clinical pharmacology research in Uganda and Africa.

Priyadharshani Galappatthy, MBBS(Col), MD(Col), MRCP(UK), DipMedTox(Cardiff), FCCP, FRCP(Lond) is Senior Professor and Chair Professor of Pharmacology, Faculty of Medicine University of Colombo, Sri Lanka. She was a World Health Organisation (WHO) Consultant, in the Patient Safety and Quality of Care Unit, Integrated Health Services Department, WHO Headquarters Geneva, Switzerland from 2022-2024 supporting the implementation of the WHO Global Patient Safety Action Plan 2021-2030. She was involved in the planning of the WHO third Global Patient Safety Challenge on Medication Without Harm, launched in 2017 and drafted the National Action Plan on medication safety in Sri Lanka launched in 2021. She currently supports the Joint Commission International on improving patient safety through their ‘Patient Safety Pathways’ initiative launched in 2025. She is deputy chair of IUPHAR Medical & Clinical Pharmacology Committee. She is a member of the Board of Directors of the National Medicines Regulatory Authority of Sri Lanka, contributing to medicines regulation in the country.

Professor David Wood is a Professor of Clinical Toxicology and Consultant Physician and Guy's and St Thomas' NHS Foundation Trust, King's Health Partners and King's College London, London, UK. He is the Chair of the UK Advisory Council on the Misuse of Drugs.

Dr. D. Figueredo received her B.A. degree (1995, Biochemistry) from Faculty of Biology, Havana University, Cuba, and both her MSc (1995, Biomedicine) and PhD (1999 Pharmaceutical Sciences) degree from National Center for Scientific Research in Havana, and most of the results were done in the Department of Toxicology at the Free University in Amsterdam. Postdoctoral training in Molecular Toxicology and pharmacology was completed at the Faculty of Pharmacy in Toronto, Canada. She has been referee of scientific journals related with pharmacology. Other previous academic appointments include lecturer in different international meeting. She has been the recipient of National Award of Pharmacology twice from the Cuban Pharmacology Society. She worked as Expert for the evaluation of preclinical platform in South Africa. (CSIR). She is the focal point to the World Health Organization network for regulatory cooperation of herbal medicines (IRCH). She is a membership committee of International Union of Pharmacology (IUPHAR). She is the secretary of Latin-American Network of Pharmacogenetic. She is currently the Vice president of Cuban Pharmacology Society. At present she works in the Cuba Regulatory Agency as senior researcher, she is in charge of the evaluation of safety and efficacy of traditional, integrative and complementary medicines for registering. Dr. Remirez research is described in over 60 published research reports.